Reviewed profile

food and beverage brand · public preview

NOVOTRIMPLUS+

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Is this your company?Claim NOVOTRIMPLUS+ to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to NOVOTRIMPLUS+ — no cold outreach.
Report a changeLog in for full recordLast reviewed 28 Mar 2026 · public preview data

Overview

What NOVOTRIMPLUS+ covers.

NovoTrimPlus+ is an injectable peptide product containing 20 mg of Tirzepatide, a dual GIP/GLP-1 receptor agonist developed for medical use. The product functions by suppressing appetite signals in the brain, slowing gastric emptying, and balancing insulin secretion to aid in weight management. It is positioned for individuals classified as overweight or obese who seek scientifically supported methods for long-term weight control. The active ingredient is manufactured in Denmark under pharmaceutical industry standards.

  • Positioned as a mainstream brand.

FAQ

Questions this page answers.

What does NOVOTRIMPLUS+ do?

NOVOTRIMPLUS+ is a food and beverage brand, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.